Abstract:Neurofibrillary tangles (NFTs), consisting of aggregates of abnormally hyperphosphorylated tau, are indicated in the pathogenesis of several neurodegenerative diseases including Alzheimer's disease (AD). Although hyperphosphorylation of tau is thought to cause aggregation and dissociation of tau from microtubules, the molecular mechanisms underlying the regulation of tau phosphorylation are largely unknown. While the PI3K/Akt pathway has increasingly been shown to regulate multiple cellular events pertinent to AD pathogenesis, including β–amyloid metabolism and tau phosphorylation via GSK–3, potential functions of tumor suppressor PTEN in AD pathogenesis have not been explored. In our study, we explored the molecular mechanisms for regulation of tau phosphorylation by asking the question that if PTEN, a tumor suppressor in PI3K/Akt signaling pathway, can affect tau phosphorylation at Akt and GSK–3 phosphorylation sites and the consequential effects on tau aggregation and binding to microtubules. We examined the effects of PTEN on tau phosphorylation, its microtubule association and formation of aggregates. We cotransfected COS–7 cells with human tau and human wild–type or phosphatase activity null mutant PTEN. We evaluated PTEN's effects on tau phosphorylation by using phospho–tau specific antibodies. To assess PTEN's effects on tau aggregation and binding to microtubules, we performed filter–retardation assay to detect and compare tau aggregates in cultured cells in the presence of wild–type or mutant PTEN. In addition, we fractioned the cotransfected cells to detect and compare the cytosolic, microtubule–bound, membrane–bound and insoluble aggregated tau between cells expressing wild–type and the mutant PTEN. Moreover, we infected rat cortical primary neurons with Sindbis viruses expressing wild–type or the mutant PTEN to monitor neuronal growth. At last, we performed immunohistology to compare phospho–tau and PTEN levels between AD patient and non–AD brains. 1. PTEN affects tau phosphorylation at Akt and GSK–3 phosphorylation sites. 2. PTEN affects tau aggregation and binding to microtubules. 3. PTEN's effects on tau phosphorylation are partially through PIP3/Akt signaling pathway.

Developmental Regulation of Tau Phosphorylation, Tau Kinases, and Tau Phosphatases

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

Essential Role of Tau Phosphorylation in Adult Hippocampal Neurogenesis

O2-01-05

Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease

Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice

Phosphorylation of Tau Antagonizes Apoptosis by Stabilizing Β-Catenin, a Mechanism Involved in Alzheimer's Neurodegeneration

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease

Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction

Phosphorylation of Tau R2 Repeat Destabilizes Its Binding to Microtubules: A Molecular Dynamics Simulation Study

Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer's disease

Phosphorylation at serine 214 correlates with tau seeding activity in an age-dependent manner in two mouse models for tauopathies and is required for tau transsynaptic propagation.

Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates

Dephosphorylation Passivates the Seeding Activity of Oligomeric Tau Derived From Alzheimer’s Brain

How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo .

Tau Ubiquitination in Alzheimer's Disease

Mass spectrometry identifies tau C-terminal phosphorylation cluster during neuronal hyperexcitation

Regulation of tau by mTor

β2 Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models

Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease